中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 41 Issue 10
Oct.  2025
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2025  >  41(10): 2062-2067

Influencing factors for quality of life in patients with primary biliary cholangitis： A systematic review

DOI: 10.12449/JCH251016

  • Department of Gastroenterology，The First Affiliated Hospital of Air Force Medical University，Xi’an 710032，China

Research funding:

National Natural Science Foundation of China (82270551)

More Information
  • Corresponding author: HAN Ying， hanying@fmmu.edu.cn （ORCID： 0000-0003-3046-9507）
  • Received Date: 2025-03-24
  • Accepted Date: 2025-06-09
  • Published Date: 2025-10-25
    Abstract
  •   Objective  To investigate the core influencing factors for quality of life in patients with primary biliary cholangitis through a systematic review， and to provide an evidence-based basis for understanding such factors.  Methods  The databases including CNKI， Wanfang Data， CBM， VIP， PubMed， Embase， Web of Science， Ovid， Scopus， and Medline were searched for articles assessing the influencing factors for quality of life in patients with primary biliary cholangitis using PBC-40 scale published up to January 11， 2025. Quality assessment was conducted using the scale compiled by the Agency for Healthcare Research and Quality， and then a qualitative evaluation was performed for the basic situation of the studies included in the analysis.  Results  A total of 11 articles were included， and the results showed that age， sex， albumin， alkaline phosphatase， gamma-glutamyl transferase， direct bilirubin， total bilirubin， total bile acid， alanine aminotransferase， aspartate aminotransferase， body mass index， and high-density lipoprotein cholesterol were important influencing factors for quality of life in patients with primary biliary cholangitis.  Conclusion  Influencing factors include demographic features， liver function parameters， and physical and metabolic indicators； however， due to the limited number of studies， more high-quality large-sample studies are needed in the future.

     

    • FullText(HTML)
  • loading
    • References(35)
  • [1]
    Chinese Society of Hepatology, Chinese Medical Association. Guidelines on the diagnosis and management of primary biliary cholangitis(2021)[J]. J Clin Hepatol, 2022, 38( 1): 35- 41.

    中华医学会肝病学分会. 原发性胆汁性胆管炎的诊断和治疗指南(2021)[J]. 临床肝胆病杂志, 2022, 38( 1): 35- 41.
    [2]
    LLEO A, WANG GQ, GERSHWIN ME, et al. Primary biliary cholangitis[J]. Lancet, 2020, 396( 10266): 1915- 1926. DOI: 10.1016/S0140-6736(20)31607-X.
    [3]
    FAISAL MS, GONZALEZ HC, GORDON SC. Primary biliary cholangitis[J]. Clin Liver Dis, 2024, 28( 1): 63- 77. DOI: 10.1016/j.cld.2023.06.005.
    [4]
    MONTALI L, GRAGNANO A, MIGLIORETTI M, et al. Quality of life in patients with primary biliary cholangitis: A cross-geographical comparison[J]. J Transl Autoimmun, 2021, 4: 100081. DOI: 10.1016/j.jtauto.2021.100081.
    [5]
    RICE S, ALBANI V, MINOS D, et al. Effects of primary biliary cholangitis on quality of life and health care costs in the United Kingdom[J]. Clin Gastroenterol Hepatol, 2021, 19( 4): 768- 776. e 10. DOI: 10.1016/j.cgh.2020.06.025.
    [6]
    ROBERTS SB, CHOI WJ, WOROBETZ L, et al. Loss of biochemical response at any time worsens outcomes in UDCA-treated patients with primary biliary cholangitis[J]. JHEP Rep, 2024, 6( 10): 101168. DOI: 10.1016/j.jhepr.2024.101168.
    [7]
    MONTANO-LOZA AJ, LYTVYAK E, HIRSCHFIELD G, et al. Prognostic scores for ursodeoxycholic acid-treated patients predict graft loss and mortality in recurrent primary biliary cholangitis after liver transplantation[J]. J Hepatol, 2024, 81( 4): 679- 689. DOI: 10.1016/j.jhep.2024.05.010.
    [8]
    TANAKA A, MA X, TAKAHASHI A, et al. Primary biliary cholangitis[J]. Lancet, 2024, 404( 10457): 1053- 1066. DOI: 10.1016/S0140-6736(24)01303-5.
    [9]
    YANG X, TANG YM. Health-related quality-of-life scales and related influencing factors in patients with primary biliary cholangitis[J]. J Clin Hepatol, 2020, 36( 9): 2129- 2132. DOI: 10.3969/j.issn.1001-5256.2020.09.050.

    杨娴, 唐映梅. 原发性胆汁性胆管炎健康相关生存质量量表及影响因素[J]. 临床肝胆病杂志, 2020, 36( 9): 2129- 2132. DOI: 10.3969/j.issn.1001-5256.2020.09.050.
    [10]
    JACOBY A, RANNARD A, BUCK D, et al. Development, validation, and evaluation of the PBC-40, a disease specific health related quality of life measure for primary biliary cirrhosis[J]. Gut, 2005, 54( 11): 1622- 1629. DOI: 10.1136/gut.2005.065862.
    [11]
    ZENG XT, LIU H, CHEN X, et al. Meta-analysis series IV: Quality evaluation tools for observational research[J]. Chin J Evid Based Cardiovasc Med, 2012, 4( 4): 297- 299. DOI: 10.3969/j.1674-4055.2012.04.004.

    曾宪涛, 刘慧, 陈曦, 等. Meta分析系列之四: 观察性研究的质量评价工具[J]. 中国循证心血管医学杂志, 2012, 4( 4): 297- 299. DOI: 10.3969/j.1674-4055.2012.04.004.
    [12]
    DYSON JK, WILKINSON N, JOPSON L, et al. The inter-relationship of symptom severity and quality of life in 2055 patients with primary biliary cholangitis[J]. Aliment Pharmacol Ther, 2016, 44( 10): 1039- 1050. DOI: 10.1111/apt.13794.
    [13]
    ZHANG S, WANG L, ZHAO LL, et al. Analysis of the relationship between health-related quality of life(primary biliary cholangitis-40) and clinical presentations of patients with primary biliary cholangitis[J]. Chin J Rheumatol, 2018, 22( 12): 798- 801. DOI: 10.3760/cma.j.issn.1007-7480.2018.12.002.

    张硕, 王立, 赵丽伶, 等. 原发性胆汁性胆管炎生活质量指标PBC-40与临床指标相关性分析[J]. 中华风湿病学杂志, 2018, 22( 12): 798- 801. DOI: 10.3760/cma.j.issn.1007-7480.2018.12.002.
    [14]
    YAGI M, TANAKA A, ABE M, et al. Symptoms and health-related quality of life in Japanese patients with primary biliary cholangitis[J]. Sci Rep, 2018, 8( 1): 12542. DOI: 10.1038/s41598-018-31063-8.
    [15]
    KAPS L, GRAMBIHLER A, YEMANE B, et al. Symptom burden and treatment response in patients with primary biliary cholangitis(PBC)[J]. Dig Dis Sci, 2020, 65( 10): 3006- 3013. DOI: 10.1007/s10620-019-06009-3.
    [16]
    MILOVANOVIC T, POPOVIC D, STOJKOVIC LALOSEVIC M, et al. Quality of life in patients with primary biliary cholangitis: A single-center experience in Serbia[J]. Dig Dis, 2020, 38( 6): 515- 521. DOI: 10.1159/000506980.
    [17]
    LIU YS, TIAN SY, JIA G, et al. Symptoms burden and health-related quality of life in Chinese patients with primary biliary cholangitis[J]. J Clin Transl Hepatol, 2021, 9( 6): 860- 867. DOI: 10.14218/JCTH.2020.00119.
    [18]
    YANG X. Health-related quality of life in patients with primary biliary cholangitis[D]. Kunming: Kunming Medical University, 2022.

    杨娴. 原发性胆汁性胆管炎患者健康相关生存质量研究[D]. 昆明: 昆明医科大学, 2022.
    [19]
    LIU M. A preliminary study on the influencing factors of life quality in patients with primary biliary cholangitis[D]. Dalian: Dalian Medical University, 2022.

    刘曼. 原发性胆汁性胆管炎患者生活质量影响因素初步探讨[D]. 大连: 大连医科大学, 2022.
    [20]
    RASZEJA-WYSZOMIRSKA J, WUNSCH E, KRAWCZYK M, et al. Assessment of health related quality of life in Polish patients with primary biliary cirrhosis[J]. Clin Res Hepatol Gastroenterol, 2016, 40( 4): 471- 479. DOI: 10.1016/j.clinre.2015.10.006.
    [21]
    JIA G, SHANG YL, HAN Y. An investigation of quality of life and treatment of patients with primary biliary cholangitis[J]. J Clin Hepatol, 2020, 36( 9): 2021- 2024. DOI: 10.3969/j.issn.1001-5256.2020.09.022.

    贾桂, 尚玉龙, 韩英. 原发性胆汁性胆管炎患者生活质量与治疗情况的调查分析[J]. 临床肝胆病杂志, 2020, 36( 9): 2021- 2024. DOI: 10.3969/j.issn.1001-5256.2020.09.022.
    [22]
    NIE WJ. Correlation analysis of clinical features, prognosis and quality of life in patients with primary biliary cirrhosis[D]. Yan’an: Yan’an University, 2021.

    聂伟杰. 原发性胆汁性胆管炎患者的临床特点、预后及生活质量相关分析[D]. 延安: 延安大学, 2021.
    [23]
    GISH RG, MACEWAN JP, LEVINE A, et al. Burden of illness for patients with primary biliary cholangitis: An observational study of clinical characteristics and healthcare resource utilization[J]. J Comp Eff Res, 2025, 14( 4): e240174. DOI: 10.57264/cer-2024-0174.
    [24]
    SOETERS PB, WOLFE RR, SHENKIN A. Hypoalbuminemia: Pathogenesis and clinical significance[J]. JPEN J Parenter Enteral Nutr, 2019, 43( 2): 181- 193. DOI: 10.1002/jpen.1451.
    [25]
    European Association for the Study of the Liver. EASL clinical practice guidelines: The diagnosis and management of patients with primary biliary cholangitis[J]. J Hepatol, 2017, 67( 1): 145- 172. DOI: 10.1016/j.jhep.2017.03.022.
    [26]
    KARATZA E, SWIFT B, CARREÑO F, et al. Serum bile acid change correlates with improvement in pruritus in patients with primary biliary cholangitis receiving linerixibat[J]. Liver Int, 2024, 44( 9): 2293- 2302. DOI: 10.1111/liv.15982.
    [27]
    LINDOR KD, BOWLUS CL, BOYER J, et al. Primary biliary cholangitis: 2018 practice guidance from the American association for the study of liver diseases[J]. Hepatology, 2019, 69( 1): 394- 419. DOI: 10.1002/hep.30145.
    [28]
    HEGADE VS, PECHLIVANIS A, MCDONALD JAK, et al. Autotaxin, bile acid profile and effect of ileal bile acid transporter inhibition in primary biliary cholangitis patients with pruritus[J]. Liver Int, 2019, 39( 5): 967- 975. DOI: 10.1111/liv.14069.
    [29]
    JIN D, WANG YW, MENG FZ, et al. Research progress on risk factors for osteoporosis secondary to primary biliary cholangitis[J]. Chin J Osteoporos Bone Miner Res, 2025, 18( 1): 120- 127. DOI: 10.3969/j.issn.1674-2591.2025.01.014.

    金迪, 王玉伟, 孟繁章, 等. 原发性胆汁性胆管炎相关骨质疏松症危险因素的研究进展[J]. 中华骨质疏松和骨矿盐疾病杂志, 2025, 18( 1): 120- 127. DOI: 10.3969/j.issn.1674-2591.2025.01.014.
    [30]
    LÖVHEIM H. A new three-dimensional model for emotions and monoamine neurotransmitters[J]. Med Hypotheses, 2012, 78( 2): 341- 348. DOI: 10.1016/j.mehy.2011.11.016.
    [31]
    SMITH HT, DAS S, FETTIPLACE J, et al. Pervasive role of pruritus in impaired quality of life in patients with primary biliary cholangitis: Data from the GLIMMER study[J]. Hepatol Commun, 2025, 9( 3): e0635. DOI: 10.1097/HC9.0000000000000635.
    [32]
    von MALTZAHN R, MAYO MJ, SMITH HT, et al. Relationship between pruritus and sleep in participants with primary biliary cholangitis in the Phase 2b GLIMMER trial[J]. J Patient Rep Outcomes, 2024, 8( 1): 60. DOI: 10.1186/s41687-024-00722-y.
    [33]
    FAISAL A. Understanding fatigue and pruritus in primary biliary cholangitis[J]. Clin Liver Dis(Hoboken), 2024, 23( 1): e0216. DOI: 10.1097/CLD.0000000000000216.
    [34]
    TAO L, ZHANG ZY, HOU DY, et al. The role and mechanism of the kynurenine/kynuric acid pathway in the muscles of mice with primary biliary cholangitis and fatigue[J]. Chin J Gastroenterol Hepatol, 2024, 33( 9): 1202- 1209.

    陶理, 张紫阳, 侯丹阳, 等. 犬尿氨酸/犬尿酸通路在原发性胆汁性胆管炎伴疲劳小鼠肌肉中的作用及机制研究[J]. 胃肠病学和肝病学杂志, 2024, 33( 9): 1202- 1209.
    [35]
    von ECKARDSTEIN A, NORDESTGAARD BG, REMALEY AT, et al. High-density lipoprotein revisited: Biological functions and clinical relevance[J]. Eur Heart J, 2023, 44( 16): 1394- 1407. DOI: 10.1093/eurheartj/ehac605.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)  / Tables(2)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (54) PDF downloads(10) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return